Literature DB >> 17329226

Medulloblastoma in young adults. Must we give adjuvant chemotherapy?

I Roussos1, C Balaña, P Cuadras, R Ballester, O Etxaniz, C Hostalot.   

Abstract

Medulloblastoma is a rare entity in adult patients. All data about treatment are from children, where this disease is the most common cerebral tumour. Reports of medulloblastoma in adults are scarce but in all of them the prognosis seems similar to the prognosis of children. We present our experience in five cases of medulloblastoma in young adults, treated at the University Hospital "Germans Trias i Pujol" from June 1994 to October 2003. This has not been a good experience as more than 50% of the patients had a recurrence in spite of the standard treatment. We have reviewed the literature, concluding that we have to adapt the findings in children to our adult patients, offering them adjuvant chemotherapy after surgery.

Entities:  

Mesh:

Year:  2007        PMID: 17329226     DOI: 10.1007/s12094-007-0024-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  1 in total

1.  Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma.

Authors:  J L Lopez Guerra; I Marrone; J Jaen; M Bruna; C Sole; A Sanchez-Reyes; E Rivin; M J Ortiz; F Calvo; R Matute
Journal:  Clin Transl Oncol       Date:  2013-04-30       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.